_2020091018165303jzv.jpg "Decoding The World Of ETF")
-
My Account
Partnered by:
Associate Partners:
My Account
Partnered by:
Associate Partners:
Partnered by:
Associate Partners:
As on 25 Jan, 2021 | 04:00
| Open | 0.00 |
| Previous Close | 0.00 |
| UC Limit | 0.00 |
| LC Limit | 0.00 |
| Volume | 0.00 |
| VWAP | 0.00 |
| Mkt Cap (Rs. Cr.) | 0 |
| 20D Avg Volume | 0 |
| 20D Avg Delivery | -- |
| Beta | 0.000.19 |
| Face Value | 0.00 |
| TTM EPS | -- |
| TTM PE | -- |
| Sector PE | 0.00 |
| Book Value Per Share | -- |
| P/B | -- |
| Dividend Yield | -- |
| P/C | -- |
*Refresh in 20 seconds.
Stock not eligible for rating
indicates Average Financials
| Revenue | 3.4% |
| NetProfit | -70.4% |
| OperatingProfit | -6.6% |
| R1 | R2 | R3 | PP | S1 | S2 | S3 | |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Trade Setup for Wednesday: Top 15 things to know before Opening Bell Jan 14 2020 07:01 PM
Trade Setup for Monday: Top 15 things to know before Opening Bell Aug 18 2019 06:08 PM
Lactose India Standalone December 2018 Net Sales at Rs 9.52 crore, up 4.43% Y-o-Y Feb 15 2019 03:02 PM
Lactose India standalone Jun '16 sales at Rs 7.97 crore Aug 12 2016 04:08 PM
This is to certify that the details of securities dematerialized during the third quarter ended 31st December, 2020, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished to BSE Li...  View more
Posted by : BSE/NSE Announcer
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quart...  View more
Posted by : BSE/NSE Announcer
Pursuant to Regulation 39(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended) (Listing Regulations, 2015) this is to inform you that the Company has received intimat...  View more
Posted by : BSE/NSE Announcer
| Qty 51000 | Price 28.01 | % Traded 0.50 |
| Qty 109277 | Price 120 | % Traded 1.07 |
| Qty 86903 | Price 188.77 | % Traded 0.85 |
| Qty 76000 | Price 185 | % Traded 0.75 |
| Qty 55300 | Price 155 | % Traded 0.54 |
| Qty 10346 | Price 146.15 | % Traded 0.10 |
| Qty 53950 | Price 155 | % Traded 0.53 |
| Qty 49000 | Price 115.17 | % Traded 0.48 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 780000 | Price 0 | % Traded 7.66 | Post Tnx Hold. 8.92% |
| Qty 75000 | Price 158.1 | % Traded 0.75 | Post Tnx Hold. 1.26% |
| Qty 75000 | Price 158.1 | % Traded 0.75 | Post Tnx Hold. 6% |
| Qty 68400 | Price 158.1 | % Traded 0.68 | Post Tnx Hold. 9.45% |
| Qty 40000 | Price 158.1 | % Traded 0.40 | Post Tnx Hold. 5.76% |
| Qty 68400 | Price 158.1 | % Traded 0.68 | Post Tnx Hold. 11.23% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 780000 | Price 0 | % Traded 7.66 | Post Tnx Hold. 8.92% |
| Qty 780000 | Price 0 | % Traded 7.66 | Post Tnx Hold. 0% |
| Qty 780000 | Price 0 | % Traded 7.66 | Post Tnx Hold. 0% |
| Qty 75000 | Price 0 | % Traded 0.74 | Post Tnx Hold. 6% |
| Qty 75000 | Price 0 | % Traded 0.74 | Post Tnx Hold. 1.26% |
| Qty 68400 | Price 0 | % Traded 0.69 | Post Tnx Hold. 9.45% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (%) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap | TTM PE | P/B | ROE | 1 Yr Perform | Net Profit | Net Sales | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Lactose India | 24.05 | -3.22 | 24.50 | - | 0.71 | 0.21 | -11.58 | 0 | 40 | 1.03 |
| Sun Pharma | 586.40 | 1.95 | 140697.00 | 84.25 | 2.86 | 8.31 | 30.95 | 4,186 | 32,837 | 0.17 |
| Divis Labs | 3569.05 | 0.69 | 94747.06 | 53.89 | 12.95 | 18.76 | 86.81 | 1,372 | 5,310 | 0.00 |
| Dr Reddys Labs | 5082.40 | 0.90 | 84519.35 | 52.53 | 5.42 | 12.98 | 67.66 | 1,969 | 17,517 | 0.11 |
| Cipla | 836.80 | 3.53 | 67484.61 | 36.67 | 4.22 | 9.81 | 82.37 | 1,546 | 17,131 | 0.18 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>
